Arkolith/Insider Trading/IOVA/Form 4

Bilinsky Igor

Chief Operating OfficerIOVANCE BIOTHERAPEUTICS, INC. (IOVA) · full profile →Form 4 · filed Sep 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 2, 2025Tax withholding(F)6K$2.19$14K100K
Sep 2, 2025Option exercise(M)12K—$0106K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 2, 2025Option exercise(M)4K—$07K
Sep 2, 2025Option exercise(M)9K—$053K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-087545) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML